CITIUS ONCOLOGY, INC. - Common stock, $0.0001 par value (CTOR) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Equity / Common stock, $0.0001 par value
Symbol
CTOR on Nasdaq
Shares outstanding
80,864,905
Price per share
$1.10
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
6,861,177
Total reported value
$6,861,177
% of total 13F portfolios
0%
Share change
-1,495,982
Value change
-$1,583,956
Number of holders
17
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CITIUS ONCOLOGY, INC. - Common stock, $0.0001 par value (CTOR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Citius Pharmaceuticals, Inc. 78% -1.5% $79,920,034 66,049,615 0% Citius Pharmaceuticals, Inc. 10 Dec 2025
ARMISTICE CAPITAL, LLC 10% +2% $8,886,244 +$442,742 8,078,404 +5.2% Armistice Capital, LLC 31 Dec 2025

As of 31 Dec 2025, 17 institutional investors reported holding 6,861,177 shares of CITIUS ONCOLOGY, INC. - Common stock, $0.0001 par value (CTOR). This represents 8.5% of the company’s total 80,864,905 outstanding shares.

Institutional Holders of CITIUS ONCOLOGY, INC. - Common stock, $0.0001 par value (CTOR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 6,861,177 $6,861,177 -$1,583,956 $1.00 17
2025 Q3 8,357,159 $16,966,429 +$16,255,712 $2.03 16
2025 Q2 227,492 $989,589 +$573,842 $4.35 7
2025 Q1 105,008 $97,657 -$115,519 $0.93 6
2024 Q4 200,884 $230,191 +$180,602 $1.15 11
2024 Q3 41,238 $57,016 +$57,016 $1.39 7